These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9931169

  • 1. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men.
    Strachan FE, Spratt JC, Wilkinson IB, Johnston NR, Gray GA, Webb DJ.
    Hypertension; 1999 Jan; 33(1 Pt 2):581-5. PubMed ID: 9931169
    [Abstract] [Full Text] [Related]

  • 2. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC, Goddard J, Patel N, Strachan FE, Rankin AJ, Webb DJ.
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [Abstract] [Full Text] [Related]

  • 3. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists.
    Allcock GH, Warner TD, Vane JR.
    Br J Pharmacol; 1995 Nov; 116(5):2482-6. PubMed ID: 8581288
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic and inotropic effects of the endothelin A antagonist BQ-610 in vivo.
    Beyer ME, Slesak G, Brehm BR, Hoffmeister HM.
    J Cardiovasc Pharmacol; 1998 Nov; 31 Suppl 1():S258-61. PubMed ID: 9595454
    [Abstract] [Full Text] [Related]

  • 5. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
    Helmy A, Jalan R, Newby DE, Johnston NR, Hayes PC, Webb DJ.
    Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of ETB receptors limits the efficacy of nonselective endothelin antagonists in vivo.
    Allcock GH, Warner TD.
    J Cardiovasc Pharmacol; 1995 Apr; 26 Suppl 3():S177-9. PubMed ID: 8587355
    [Abstract] [Full Text] [Related]

  • 7. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.
    Goddard J, Johnston NR, Hand MF, Cumming AD, Rabelink TJ, Rankin AJ, Webb DJ.
    Circulation; 2004 Mar 09; 109(9):1186-93. PubMed ID: 14981006
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular and renal actions of the endothelin(B) receptor in pigs.
    Cirino M, Martin E, Yano M, Rodger IW.
    J Cardiovasc Pharmacol; 1997 Jun 09; 29(6):704-12. PubMed ID: 9234650
    [Abstract] [Full Text] [Related]

  • 9. Effects of selective endothelin antagonists on the hemodynamic response to cyclosporin A.
    Davis LS, Haleen SJ, Doherty AM, Cody WL, Keiser JA.
    J Am Soc Nephrol; 1994 Jan 09; 4(7):1448-54. PubMed ID: 8161726
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prolonged endothelin B receptor blockade causes pulmonary hypertension in the ovine fetus.
    Ivy DD, Parker TA, Abman SH.
    Am J Physiol Lung Cell Mol Physiol; 2000 Oct 09; 279(4):L758-65. PubMed ID: 11000137
    [Abstract] [Full Text] [Related]

  • 12. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
    Gardiner SM, Kemp PA, March JE, Bennett T, Davenport AP, Edvinsson L.
    Br J Pharmacol; 1994 Jun 09; 112(2):477-86. PubMed ID: 8075866
    [Abstract] [Full Text] [Related]

  • 13. Hyperresponsiveness to ET-1 after treatment with a mixture of ETA and ETB receptor antagonists in the rabbit in vivo and in vitro.
    D'Orléans-Juste P, Yano M, Maurice MC, Gratton JP.
    J Cardiovasc Pharmacol; 1995 Jun 09; 26 Suppl 3():S369-72. PubMed ID: 8587417
    [Abstract] [Full Text] [Related]

  • 14. Direct comparison of selective endothelin A and non-selective endothelin A/B receptor blockade in chronic heart failure.
    Leslie SJ, Spratt JC, McKee SP, Strachan FE, Newby DE, Northridge DB, Denvir MA, Webb DJ.
    Heart; 2005 Jul 09; 91(7):914-9. PubMed ID: 15958361
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors.
    Lipa JE, Neligan PC, Perreault TM, Baribeau J, Levine RH, Knowlton RJ, Pang CY.
    Am J Physiol; 1999 Feb 09; 276(2):H359-67. PubMed ID: 9950834
    [Abstract] [Full Text] [Related]

  • 19. Endothelin A receptor antagonism and angiotensin-converting enzyme inhibition are synergistic via an endothelin B receptor-mediated and nitric oxide-dependent mechanism.
    Goddard J, Eckhart C, Johnston NR, Cumming AD, Rankin AJ, Webb DJ.
    J Am Soc Nephrol; 2004 Oct 09; 15(10):2601-10. PubMed ID: 15466264
    [Abstract] [Full Text] [Related]

  • 20. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
    Holm P.
    Scand Cardiovasc J Suppl; 1997 Oct 09; 46():1-40. PubMed ID: 9265559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.